Center for Scientific Review; Notice of Closed Meetings, 16107-16108 [2020-05813]
Download as PDF
Federal Register / Vol. 85, No. 55 / Friday, March 20, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Center for Scientific Review; Notice of
Closed Meetings
Notice is hereby given of a change in
the meeting of the National Institute of
Child Health and Human Development
Special Emphasis Panel, IDDRC Review
Intellectual and Developmental
Disabilities Research Centers 2020,
April 21, 2020, 08:00 a.m. to April 22,
2020, 05:00 p.m. which was published
in the Federal Register on March 06,
2020, 85 FR 10707.
The meeting format has changed from
in-person meeting to a teleconference
meeting. The meeting is closed to the
public.
Dated: March 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05820 Filed 3–19–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Institute Special Emphasis
Panel, April 7, 2020, 08:00 a.m. to April
7, 2020, 12:30 p.m., Embassy Suites—
Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015 which
was published in the Federal Register
on March 04, 2020, 85 FR 12799.
The NHLBI Special Emphasis Panel
meeting is being amended due to a
change in the meeting format. This one
day meeting to be held on April 7, 2020
will be a teleconference meeting. The
meeting is closed to the public.
Dated: March 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05818 Filed 3–19–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:01 Mar 19, 2020
Jkt 250001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; High-End
Instrumentation (HEI) Grant Program (S10
Clinical Trial Not Allowed).
Date: April 6, 2020.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Songtao Liu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5118,
Bethesda, MD 20817, 301–827–6828,
songtao.liu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RM18–009:
NIH Transformative Research Awards (R01)
Review.
Date: April 7, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Raymond Jacobson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5858,
MSC 7849, Bethesda, MD 20892, 301–996–
7702, jacobsonrh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and Related Research.
Date: April 7, 2020.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
16107
20892, 301–402–9448, shinako.takada@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and Related Research.
Date: April 7, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
Bethesda, MD 20892, 301–451–8754, tuoj@
nei.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–MH–
20–520: Implementation Research in HRSA
Ryan White Sites.
Date: April 8, 2020.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3190, Bethesda, MD 20892, 301–827–
7480, dimitrios.vatakis@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Population Sciences and
Epidemiology.
Date: April 8, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Denise Wiesch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, wieschd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Social
Psychology, Personality, and Interpersonal
Processes.
Date: April 8, 2020.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Marc Boulay, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, (301) 300–
6541, boulaymg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: April 8, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\20MRN1.SGM
20MRN1
jbell on DSKJLSW7X2PROD with NOTICES
16108
Federal Register / Vol. 85, No. 55 / Friday, March 20, 2020 / Notices
Place: National Institutes of Health, 6701
Rockledge Dr., Bethesda, MD 20817 (Virtual
Meeting).
Contact Person: Sarita Kandula Sastry,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20782, sarita.sastry@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Chronic Neurodegenerative and
Neurodevelopment Disorders.
Date: April 9, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–GM–
19–001: Methods to Improve Reproducibility
of Human iPSC Derivation, Growth and
Differentiation (SBIR).
Date: April 9, 2020.
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Raj K. Krishnaraju, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
Bethesda, MD 20892, 301–435–1047,
kkrishna@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Autoimmunity, Transplantation and
Tumor.
Date: April 9, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4203,
Bethesda, MD 20892, (301) 435–3566,
alok.mulky@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Toxicology and Pharmacology.
Date: April 9, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Julia Spencer Barthold,
MD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–402–3073, julia.barthold@
nih.gov.
VerDate Sep<11>2014
19:01 Mar 19, 2020
Jkt 250001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
20–005: Mechanistic Basis of TDP–43Dependent Pathobiology in Common
Dementias.
Date: April 14, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7850, Bethesda, MD 20892, (301) 435–
1203, laurent.taupenot@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA panel:
A2CPS—Multisite Clinical Centers.
Date: April 14, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892–7814, 301–
435–1787, borzanj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05813 Filed 3–19–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2016–1084]
RIN 1625–ZA39
Navigation and Vessel Inspection
Circular (NVIC) 01–20; Guidelines for
Addressing Cyber Risks at Maritime
Transportation Security Act (MTSA)
Regulated Facilities
Coast Guard, DHS.
Notice of availability.
AGENCY:
ACTION:
SUMMARY: The Coast Guard announces
the availability of Navigation and Vessel
Inspection Circular (NVIC) 01–20, titled
Guidelines for Addressing Cyber Risks
at Maritime Transportation Security Act
(MTSA) Regulated Facilities. This NVIC
clarifies the existing MTSA
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
requirements related to computer
system and network vulnerabilities of
MTSA-regulated facilities. It also
provides owners and operators of the
facilities with guidance on how to
analyze these vulnerabilities in their
required Facility Security Assessment
(FSA) and address them in the Facility
Security Plan (FSP).
FOR FURTHER INFORMATION CONTACT: If
you have questions on this notice, call
or email, CDR Brandon Link, U.S. Coast
Guard; telephone 202–372–1107, email
Brandon.M.Link@uscg.mil.
SUPPLEMENTARY INFORMATION:
Discussion
As discussed in the United States
Coast Guard Cyber Security Strategy,
released in June 2015,1 and the draft
NVIC,2 published for public comment
on July 12, 2017 (82 FR 32189), cyber
security is one of the most serious
economic and national security
challenges for the maritime industry
and our nation. Maritime facility safety
and security systems, such as security
monitoring, fire detection, and general
alarm installations increasingly rely on
computer systems and networks. While
these computer systems and networks
create benefits, they are inherently
vulnerable and introduce new
vulnerabilities.
There are many resources, technical
standards, and recommended practices
available to the maritime industry that
can help with identifying vulnerabilities
to facility computer systems and
networks and subsequently
incorporating those vulnerabilities into
FSPs. However, recent Coast Guard
experience suggests the maritime
industry may not be aware of or
utilizing these resources. Therefore, this
NVIC recommends how MTSAregulated facilities can address and
mitigate cyber security risks while
ensuring the continued operational
capability of the nation’s Marine
Transportation System (MTS).
The Maritime Transportation Security
Act of 2002 (MTSA) (Pub. L. 107–295,
November 25, 2002, as codified in 46
U.S.C. Chapter 701) addresses the
security of the MTS and authorizes the
Coast Guard to prescribe regulations.
Under the authority of MTSA, the Coast
Guard promulgated regulations in
subchapter H of Title 33 of the Code of
Federal Regulations (CFR). These
1 https://www.uscg.mil/Portals/0/Strategy/
Cyber%20Strategy.pdf.
2 The Coast Guard assigns NVICs based on the
year and order in which they are issued in the final
form. The draft version of this NVIC was assigned
NVIC number 05–17. However, since the final
version of the NVIC will be issued in the year 2020,
we have assigned it a new number 01–20.
E:\FR\FM\20MRN1.SGM
20MRN1
Agencies
[Federal Register Volume 85, Number 55 (Friday, March 20, 2020)]
[Notices]
[Pages 16107-16108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; High-End Instrumentation (HEI) Grant Program (S10 Clinical
Trial Not Allowed).
Date: April 6, 2020.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Songtao Liu, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5118, Bethesda, MD 20817, 301-827-6828,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RM18-009: NIH Transformative Research Awards (R01) Review.
Date: April 7, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raymond Jacobson, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5858, MSC 7849, Bethesda, MD
20892, 301-996-7702, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and Related Research.
Date: April 7, 2020.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shinako Takada, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-402-9448,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and Related Research.
Date: April 7, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5207, Bethesda, MD 20892, 301-451-8754,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-MH-20-520: Implementation Research in HRSA Ryan White
Sites.
Date: April 8, 2020.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3190, Bethesda, MD 20892, 301-
827-7480, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Population Sciences and Epidemiology.
Date: April 8, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Denise Wiesch, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3138, MSC 7770, Bethesda, MD 20892, (301) 437-
3478, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Social Psychology, Personality, and Interpersonal Processes.
Date: April 8, 2020.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Marc Boulay, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, (301) 300-
6541, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Biology.
Date: April 8, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 16108]]
Place: National Institutes of Health, 6701 Rockledge Dr.,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Sarita Kandula Sastry, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20782,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Chronic Neurodegenerative and
Neurodevelopment Disorders.
Date: April 9, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-GM-19-001: Methods to Improve Reproducibility of Human
iPSC Derivation, Growth and Differentiation (SBIR).
Date: April 9, 2020.
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raj K. Krishnaraju, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190, Bethesda, MD 20892, 301-
435-1047, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Autoimmunity, Transplantation and Tumor.
Date: April 9, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alok Mulky, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4203, Bethesda, MD 20892, (301) 435-3566,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Toxicology and Pharmacology.
Date: April 9, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Julia Spencer Barthold, MD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-402-3073,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-20-005: Mechanistic Basis of TDP-43-Dependent
Pathobiology in Common Dementias.
Date: April 14, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laurent Taupenot, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188, MSC 7850, Bethesda, MD
20892, (301) 435-1203, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA panel: A2CPS--Multisite Clinical Centers.
Date: April 14, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jasenka Borzan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD
20892-7814, 301-435-1787, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 16, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-05813 Filed 3-19-20; 8:45 am]
BILLING CODE 4140-01-P